rs76352345

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_006267.5(RANBP2):​c.816G>C​(p.Leu272Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0159 in 1,597,456 control chromosomes in the GnomAD database, including 594 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.014 ( 63 hom., cov: 32)
Exomes 𝑓: 0.016 ( 531 hom. )

Consequence

RANBP2
NM_006267.5 missense

Scores

1
2
15

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.531

Publications

13 publications found
Variant links:
Genes affected
RANBP2 (HGNC:9848): (RAN binding protein 2) RAN is a small GTP-binding protein of the RAS superfamily that is associated with the nuclear membrane and is thought to control a variety of cellular functions through its interactions with other proteins. This gene encodes a very large RAN-binding protein that immunolocalizes to the nuclear pore complex. The protein is a giant scaffold and mosaic cyclophilin-related nucleoporin implicated in the Ran-GTPase cycle. The encoded protein directly interacts with the E2 enzyme UBC9 and strongly enhances SUMO1 transfer from UBC9 to the SUMO1 target SP100. These findings place sumoylation at the cytoplasmic filaments of the nuclear pore complex and suggest that, for some substrates, modification and nuclear import are linked events. This gene is partially duplicated in a gene cluster that lies in a hot spot for recombination on chromosome 2q. [provided by RefSeq, Jul 2008]
RANBP2 Gene-Disease associations (from GenCC):
  • familial acute necrotizing encephalopathy
    Inheritance: AD Classification: STRONG, LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • Leigh syndrome
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0019601583).
BP6
Variant 2-108740522-G-C is Benign according to our data. Variant chr2-108740522-G-C is described in ClinVar as Benign. ClinVar VariationId is 381173.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.0833 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RANBP2NM_006267.5 linkc.816G>C p.Leu272Phe missense_variant Exon 7 of 29 ENST00000283195.11 NP_006258.3 P49792

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RANBP2ENST00000283195.11 linkc.816G>C p.Leu272Phe missense_variant Exon 7 of 29 1 NM_006267.5 ENSP00000283195.6 P49792

Frequencies

GnomAD3 genomes
AF:
0.0138
AC:
2100
AN:
152124
Hom.:
53
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00217
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.00786
Gnomad ASJ
AF:
0.00576
Gnomad EAS
AF:
0.0349
Gnomad SAS
AF:
0.0900
Gnomad FIN
AF:
0.0385
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.0119
Gnomad OTH
AF:
0.0153
GnomAD2 exomes
AF:
0.0207
AC:
4948
AN:
238564
AF XY:
0.0238
show subpopulations
Gnomad AFR exome
AF:
0.00157
Gnomad AMR exome
AF:
0.00415
Gnomad ASJ exome
AF:
0.00561
Gnomad EAS exome
AF:
0.0323
Gnomad FIN exome
AF:
0.0349
Gnomad NFE exome
AF:
0.0114
Gnomad OTH exome
AF:
0.0178
GnomAD4 exome
AF:
0.0161
AC:
23300
AN:
1445214
Hom.:
531
Cov.:
32
AF XY:
0.0180
AC XY:
12943
AN XY:
719326
show subpopulations
African (AFR)
AF:
0.00186
AC:
62
AN:
33402
American (AMR)
AF:
0.00528
AC:
236
AN:
44712
Ashkenazi Jewish (ASJ)
AF:
0.00490
AC:
128
AN:
26128
East Asian (EAS)
AF:
0.0353
AC:
1399
AN:
39682
South Asian (SAS)
AF:
0.0758
AC:
6529
AN:
86160
European-Finnish (FIN)
AF:
0.0330
AC:
1290
AN:
39144
Middle Eastern (MID)
AF:
0.00484
AC:
20
AN:
4134
European-Non Finnish (NFE)
AF:
0.0112
AC:
12429
AN:
1111736
Other (OTH)
AF:
0.0201
AC:
1207
AN:
60116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.455
Heterozygous variant carriers
0
1496
2992
4487
5983
7479
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
546
1092
1638
2184
2730
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0139
AC:
2120
AN:
152242
Hom.:
63
Cov.:
32
AF XY:
0.0165
AC XY:
1226
AN XY:
74438
show subpopulations
African (AFR)
AF:
0.00217
AC:
90
AN:
41538
American (AMR)
AF:
0.00785
AC:
120
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.00576
AC:
20
AN:
3470
East Asian (EAS)
AF:
0.0348
AC:
180
AN:
5178
South Asian (SAS)
AF:
0.0903
AC:
436
AN:
4828
European-Finnish (FIN)
AF:
0.0385
AC:
408
AN:
10594
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.0119
AC:
810
AN:
68022
Other (OTH)
AF:
0.0255
AC:
54
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
98
196
294
392
490
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
36
72
108
144
180
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0145
Hom.:
55
Bravo
AF:
0.00913
TwinsUK
AF:
0.0154
AC:
57
ALSPAC
AF:
0.00804
AC:
31
ESP6500AA
AF:
0.00293
AC:
12
ESP6500EA
AF:
0.0105
AC:
82
ExAC
AF:
0.0219
AC:
2612
Asia WGS
AF:
0.115
AC:
401
AN:
3478
EpiCase
AF:
0.00987
EpiControl
AF:
0.0105

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Mar 14, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Familial acute necrotizing encephalopathy Benign:1
Jan 20, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.075
BayesDel_addAF
Benign
-0.68
T
BayesDel_noAF
Benign
-0.69
CADD
Benign
18
DANN
Uncertain
0.99
DEOGEN2
Benign
0.26
T
Eigen
Benign
-0.73
Eigen_PC
Benign
-0.59
FATHMM_MKL
Uncertain
0.90
D
LIST_S2
Benign
0.39
T
MetaRNN
Benign
0.0020
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.69
N
PhyloP100
0.53
PrimateAI
Benign
0.30
T
PROVEAN
Benign
-1.0
N
REVEL
Benign
0.047
Sift
Benign
0.17
T
Sift4G
Pathogenic
0.0010
D
Polyphen
0.026
B
Vest4
0.050
MutPred
0.18
Loss of loop (P = 0.0112);
MPC
0.43
ClinPred
0.0018
T
GERP RS
0.92
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.028
gMVP
0.16
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs76352345; hg19: chr2-109356978; COSMIC: COSV51702822; COSMIC: COSV51702822; API